UPDATE 3-GSK stays strong as healthy sales beat expectations ...Middle East

Opinion by : (Devdiscourse) -
GSK began 2023 with a quarterly performance that beat analyst expectations and extended a series of positive results following strong sales of its roster of vaccines as well as HIV and respiratory medicines. It reaffirmed its guidance for 2023, saying it expected adjusted operating profit growth to be higher in the second half, but lower in the first half of the year when expected drug launches will increase costs.

Hence then, the article about update 3 gsk stays strong as healthy sales beat expectations was published today ( ) and is available on Devdiscourse ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( UPDATE 3-GSK stays strong as healthy sales beat expectations )

Last updated :

Also on site :

Most Viewed Opinion
جديد الاخبار